The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart), ...

Diabetes is one of the most common health conditions worldwide, yet many misconceptions surround it. These myths often lead ...

Over the past couple of years, there's been a huge interest in how our blood glucose levels fluctuate throughout the day, ...